Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

CORRECTION: Iridex Q2 EPS $(0.06) Misses $0.06 Estimate, Sales $13.57M Up From $12.63M YoY

Author: Benzinga Newsdesk | August 12, 2025 05:55pm
Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $0.06 by 200 percent. This is a 62.5 percent increase over losses of $(0.16) per share from the same period last year. The company reported $13.57 million in sales this quarter. This is a 7.44 percent increase over sales of $12.63 million the same period last year.

Posted In: IRIX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist